Browse EX-10 agreements

RESALE ORGANIZATION AGREEMENT

This Resale Organization Agreement (this “Agreement”) is entered into as of April 14, 2026, by and among Stereotaxis, Inc., a Delaware corporation (the “Purchaser”), and the sellers listed on Exhibit A hereto (each, a “Seller,” and collectively, the “Sellers”).

RECITALS

WHEREAS, Purchaser and the Sellers have entered into that certain Share Sale Agreement, dated as of April 14, 2026 (the “SPA”), pursuant to which Purchaser has agreed to issue to the Sellers shares of Purchaser Common Stock and Purchaser Warrants as consideration for the acquisition of their securities of Robocath S.A.;

WHEREAS, pursuant to Section 2.2(a)(v) of the SPA, the parties have agreed to enter into this Agreement to govern the orderly resale of Registrable Securities following the Closing;

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

ARTICLE I — DEFINITIONS

…

---

Exhibit 10.1

EXECUTION VERSION

WARRANT ISSUANCE AGREEMENT

This WARRANT ISSUANCE AGREEMENT (this “Agreement”) is entered into as of May 12, 2026 (the “Effective Date”), between Oaktree Capital Management, L.P., acting on behalf of certain funds and accounts managed by it or an affiliate, in each case, within its Global Private Debt strategy, or one or more entities owned by such funds or accounts (the “Purchaser”), and Aquestive Therapeutics, Inc., a corporation incorporated in the State of Delaware (the “Company”).

WHEREAS, the Company, the guarantors party thereto from time to time, the lenders party thereto from time to time (including the Purchaser) and Oaktree Fund Administration, LLC, as administrative agent (the “Administrative Agent”), are party to that certain Credit Agreement and Guaranty, dated as of May 12, 2026 (the “Credit Agreement”);

…

---

Exhibit 10.3

Execution Version

 

SECURITY AGREEMENT

 

by and among

 

AQUESTIVE THERAPEUTICS, INC.,

 

a Delaware corporation,

 

Borrower’s Subsidiaries having acceded hereto pursuant to Section 24,

 

and

 

OAKTREE FUND ADMINISTRATION, LLC,

 

as Administrative Agent for the Lenders referred to below

 

Dated as of May 12, 2026

 

 

---

TABLE OF CONTENTS

 

Page

 

SECTION 1

Definitions; Interpretation.

1

 

 

 

SECTION 2

Security Interest.

7

 

 

 

SECTION 3

Perfection and Priority.

8

 

 

 

SECTION 4

Representations and Warranties

12

 

 

 

SECTION 5

Covenants

17

 

 

 

SECTION 6

Rights to Payment and Pledged Collateral.

21

 

 

 

SECTION 7

Authorization; Agent Appointed Attorney-in-Fact

25

 

 

 

SECTION 8

Agent Performance of Grantor Obligations

27

 

 

 

SECTION 9

Agent’s Duties

27

 

 

 

SECTION 10

Remedies.

28

 

 

 

SECTION 11

Certain Waivers

32

 

 

 

SECTION 12

Notices

32

 

 

 

SECTION 13

No Waiver; Cumulative Remedies

33

 

 

 

SECTION 14

Costs and Expenses; Indemnification.

…

---

Exhibit 10.2

 

Execution Version

 

THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

 

---

CREDIT AGREEMENT AND GUARANTY

 

dated as of May 12, 2026

 

by and among

 

AQUESTIVE THERAPEUTICS, INC.,

as the Borrower,

 

THE GUARANTORS FROM TIME TO TIME PARTY HERETO,

as the Guarantors,

 

THE LENDERS FROM TIME TO TIME PARTY HERETO

 

as the

 

Lenders,

 

and

 

OAKTREE FUND ADMINISTRATION, LLC,

as the Administrative Agent

 

U.S. $150,000,000

---

---

TABLE OF CONTENTS

 

 

Page

 

 

SECTION 1. DEFINITIONS

1

 

 

 

1.01

Certain Defined Terms

1

 

1.02

Accounting Terms and Principles

40

 

1.03

Interpretation

41

 

1.04

Division

42

 

 

 

 

SECTION 2. THE COMMITMENT AND THE LOANS

42

 

 

 

2.01

Loans.

42

 

2.02

Borrowing Procedures.

43

 

2.03

Funding of Borrowings

43

 

2.04

Notes

44

 

2.05

Use of Proceeds

44

 

2.06

…

EX-10.3.1

Exhibit 10.3.1

 

ORDER FORM

 

Anchorage Contact

  

Client Contact

Name: Matthew Zablotny

  

Name: Cynthia Lo Bessette

Email: [redacted]

  

Email: [redacted]

This AMENDED AND RESTATED MASTER CUSTODY SERVICE AGREEMENT (“Agreement”) is made and entered into as of the Effective Date provided herein, by and between Anchorage Digital Bank N.A. (“Anchorage”,) and each fund listed on Schedule C (each a “Client”) (Anchorage and Client, each a “Party” and collectively, the “Parties”) and fully amends and restates the Master Custody Service Agreement (“Original Agreement”) entered into by the Parties dated September 22, 2025. Each Client, acting through FD Funds Management LLC (the “Agent”), severally and not jointly enters into this Agreement with Anchorage. This Agreement shall constitute separate agreements, each between a single Client and Anchorage, as if such Client had executed a separate Agreement naming only itself as the Client, and no Client shall have any liability for the obligations of any other Client. Any reference

…

AMENDED AND RESTATED

SPONSOR AGREEMENT

THIS AMENDED AND RESTATED SPONSOR AGREEMENT (the “Agreement”), dated as of __, 2026, is made by and between FD Funds Management LLC, a Delaware limited liability company (“Sponsor”), and Fidelity Ethereum Fund, a statutory trust organized under the laws of Delaware (the “Trust”).

WHEREAS, the Sponsor and the Trust entered into that certain Original Sponsor Agreement dated June 3, 2024 (the “Original Sponsor Agreement”); and

WHEREAS, the Sponsor and the Trust desire to amend and restate the Original Sponsor Agreement in its entirety as set forth herein.

NOW, THEREFORE, in consideration of the premises and of the mutual agreements herein contained, the Sponsor and the Trust hereby amend and restate the Original Sponsor Agreement and agree as follows:

…

EX-10.3.2

Exhibit 10.3.2

BITGO CUSTODIAL SERVICES AGREEMENT

WHEREAS;

 

 

A.

Custodian provides Services related to Digital Assets and Fiat Currencies; and

 

 

B.

Each Client desires to open, and Custodian wishes to provide, a Custodial Account, as provided below.

NOW THEREFORE, in consideration of the mutual promises contained herein, the parties hereby agree:

This Custodial Services Agreement is made as of the later date of the signatures below (the “Effective Date”) by and between each fund specified on Schedule B (each a “Client” and collectively the “Clients”), by and through its sponsor and agent, FD Funds Management LLC, acting solely in its capacity as such (“Sponsor”), and Custodian, as defined below. This Agreement governs Client’s use of the Custodial Services, APIs, and Staking Services (each as defined below, and collectively, the “Services”) provided or made available by the Custodian. Each Client severally and not jointly enters into this Agreement with Custodian. This Agreement shall constitute separate agreements, each between a single Client

…

FORM OF AUTHORIZED PARTICIPANT MASTER AGREEMENT

Fidelity Digital Assets

This Authorized Participant Master Agreement (the “Agreement”) is entered into between Fidelity Distributors Company LLC (the “Distributor”) and [________________________________________] (the “Participant”) and is subject to acceptance by State Street Bank and Trust Company (the “Transfer Agent”). The Distributor, the Participant and the Transfer Agent acknowledge and agree that each Trust listed on Attachment C, as may be amended from time to time, (each, a “Trust” and, collectively, the “Trusts”) is structured as an exchange-traded commodity fund and shall be a third-party beneficiary of this Agreement and shall receive the benefits contemplated by this Agreement to the extent specified herein. Capitalized terms used but not defined herein are defined in the current prospectus for each Trust (the “Prospectus”).

…

April 11, 2026

 

STRICTLY CONFIDENTIAL

 

Bluejay Diagnostics, Inc.

360 Massachusetts Avenue, Suite 203

Acton, MA 01720

 

Attn: Neil Dey, President and Chief Executive Officer

 

Dear Mr. Dey:

 

This letter agreement (this “Agreement”) constitutes the agreement between Bluejay Diagnostics, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive underwriter, agent or advisor in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainw

…

MICROVISION, INC.

AMENDMENT NO. 1 TO AT-THE-MARKET SALES AGREEMENT

June 12, 2026

 

Deutsche Bank Securities Inc.

1 Columbus Circle

New York, New York 10019

 

Mizuho Securities USA LLC

1271 Avenue of the Americas

New York, New York 10020

 

Craig-Hallum Capital Group LLC

222 South 9th Street, Suite 350

Minneapolis, MN 55402

 

Ladies and Gentlemen:

 

Reference is made to the At-the-Market Sales Agreement, dated March 5, 2024 (the “Agreement”), by and between MicroVision, Inc., a Delaware corporation (the “Company”), and Deutsche Bank Securities Inc., Mizuho Securities USA LLC and Craig-Hallum Capital Group LLC (the “Agents”). Capitalized terms used herein but not otherwise defined are used herein as defined in the Agreement.

…

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of May 14, 2026 by and among Whitehawk Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).

RECITALS

WHEREAS, the Company and the Purchasers are parties to a Securities Purchase Agreement, dated as of May 12, 2026 (the “Purchase Agreement”), pursuant to which the Purchasers are purchasing shares of capital stock and/or pre-funded warrants of the Company; and

WHEREAS, in connection with the consummation of the transactions contemplated by the Purchase Agreement, and pursuant to the terms of the Purchase Agreement, the parties desire to enter into this Agreement in order to grant certain rights to the Purchasers as set forth below.

…